NCT03184740

Brief Summary

Technological advances and non-invasive techniques to modulate brain function have been developed, including transcranial Direct Current Stimulation (tDCS). Basically, electrodes are placed on the brain regions to stimulate or inhibit it. Subsequently, a continuous electrical current (0.4-2 mA) is imposed, for a period of 3-20 minutes, to modify cortical excitability. Few are the research groups that work on the topic of primary dysmenorrhea and the use of tDCS as the focus of study. Preliminary studies associated the use of tDCS with pain reduction, but the outcomes of physical and behavioral function needs further investigation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2017

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

June 7, 2017

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 14, 2017

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2017

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2017

Completed
Last Updated

September 12, 2017

Status Verified

September 1, 2017

Enrollment Period

2 months

First QC Date

June 7, 2017

Last Update Submit

September 9, 2017

Conditions

Outcome Measures

Primary Outcomes (8)

  • Changes in pain

    Pain diary will be used to assess pain levels

    It will be used throughout the first and second menstrual cycle (approximately 60 days).

  • Changes in pain

    Visual Analogue Scale will be used to measure pain levels

    First evaluation will be done between the first and third days of initial menstrual cycle. The second evaluation will be done between the first and third days of the next menstrual cycle

  • Changes in anxiety levels

    Hamilton anxiety rating scale will be used to measure anxiety levels

    First evaluation will be done between the first and third days of initial menstrual cycle. The second evaluation will be done between the first and third days of the next menstrual cycle

  • Changes in affectivity

    Positive And Negative Affect Scale will be used to measure affectivity

    First evaluation will be done between the first and third days of initial menstrual cycle. The second evaluation will be done between the first and third days of the next menstrual cycle

  • Changes in local pain levels

    Digital pressure algometry will be used to measure local pain levels

    First evaluation will be done between the first and third days of initial menstrual cycle. The second evaluation will be done between the first and third days of the next menstrual cycle

  • Changes in hand strength

    Hydraulic hand dynamometer will be used to measure hand strength

    First evaluation will be done between the first and third days of initial menstrual cycle. The second evaluation will be done between the first and third days of the next menstrual cycle

  • Changes in functional capacity

    Six-minute walk test will be used to measure functional capacity

    First evaluation will be done between the first and third days of initial menstrual cycle. The second evaluation will be done between the first and third days of the next menstrual cycle

  • Changes in flexibility

    Thomas test will be used to measure flexibility

    First evaluation will be done between the first and third days of initial menstrual cycle. The second evaluation will be done between the first and third days of the next menstrual cycle

Study Arms (2)

Active-tDCS

EXPERIMENTAL

A constant current (anodic) of 2mA will be applied for 20 minutes over the Primary motor cortex (M1).

Device: Active Transcranial Direct Current Stimulation

Sham-tDCS

SHAM COMPARATOR

A constant current (sham) of 2mA will be applied on the Primary motor cortex, but the stimulator will be turned off after 30 seconds .

Device: Sham Transcranial Direct Current Stimulation

Interventions

For electrode placement, the criteria used by the 10/20 electroencephalography system will be obeyed and the electrodes will be positioned over Primary motor cortex, C3 area for the anode and Fp2 (contralateral supraorbital area) for the cathode electrode. A constant current of 2mA will be applied for 20 minutes.

Active-tDCS

For electrode placement, the criteria used by the 10/20 electroencephalography system will be obeyed and the electrodes will be positioned over primary motor cortex, C3 area for the anode and Fp2 (contralateral supraorbital area) for the cathode electrode, but the stimulator will be turned off after 30 seconds of stimulation.

Sham-tDCS

Eligibility Criteria

Age18 Years - 60 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • \- to have primary dysmenorrhea symptoms for more than 6 months with a mean perception of at least 3 (on a scale of 0 to 10) on the visual analogue scale, to have a regular menstrual cycle from 28 to 32 days.

You may not qualify if:

  • \- Participants will be excluded if they have history of genitourinary disease (infectious oncology or infection), neurogenic bladder dysfunction, to have alcohol or drug abuse in the last 6 months, to have severe depression (score greater than 30 on the Beck depression inventory), to have previously neurological disorders diagnosis and to be pregnant.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Federal University of Rio Grande do Norte

Santa Cruz, Rio Grande do Norte, 59200-000, Brazil

Location

MeSH Terms

Conditions

PainMental Disorders

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Master student

Study Record Dates

First Submitted

June 7, 2017

First Posted

June 14, 2017

Study Start

June 1, 2017

Primary Completion

July 31, 2017

Study Completion

August 31, 2017

Last Updated

September 12, 2017

Record last verified: 2017-09

Locations